Alexion Pharmaceuticals

URI: https://gptkb.org/entity/Alexion_Pharmaceuticals
GPTKB entity
Statements (43)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:acquisition gptkb:Zymeworks
gptkb:Astra_Zeneca
gptkb:Achillion_Pharmaceuticals
gptkb:Portola_Pharmaceuticals
gptkb:Syntimmune
gptkb:Cure_Vac
Astra Zeneca's rare disease unit
Wilson Therapeutics
gptkbp:ceo gptkb:David_Hallal
gptkbp:clinical_trial gptkb:ALXN1210
gptkb:ALXN1830
gptkb:ALXN2060
gptkbp:employees approximately 3,000
gptkbp:founded gptkb:1992
gptkbp:founder gptkb:Leonard_Bell
gptkbp:headquarters gptkb:Boston,_Massachusetts
https://www.w3.org/2000/01/rdf-schema#label Alexion Pharmaceuticals
gptkbp:notable_products gptkb:Soliris
gptkb:Ultomiris
gptkbp:partnership gptkb:Zymeworks
gptkb:Takeda_Pharmaceutical_Company
gptkb:Sanofi_Genzyme
gptkb:Astra_Zeneca
gptkb:Sanofi
gptkb:Boehringer_Ingelheim
gptkb:Bristol-Myers_Squibb
gptkb:Eisai_Co.,_Ltd.
gptkb:Pfizer
gptkb:Regeneron_Pharmaceuticals
gptkb:Amgen
gptkb:Cure_Vac
gptkb:Novartis
gptkbp:research_areas neurology
hematology
immunology
gptkbp:revenue $2.4 billion (2020)
gptkbp:specializes_in rare diseases
gptkbp:stock_symbol gptkb:ALXN
gptkbp:subsidiary gptkb:Syntimmune
gptkbp:website www.alexion.com
gptkbp:bfsParent gptkb:Astra_Zeneca
gptkbp:bfsLayer 4